LEADER 05480nam 22006615 450 001 9910254535003321 005 20200705075425.0 010 $a3-319-34141-3 024 7 $a10.1007/978-3-319-34141-5 035 $a(CKB)3710000000829684 035 $a(DE-He213)978-3-319-34141-5 035 $a(MiAaPQ)EBC4644713 035 $a(PPN)194806286 035 $a(EXLCZ)993710000000829684 100 $a20160802d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aInterventional Therapies for Secondary and Essential Hypertension /$fedited by Costas Tsioufis, Roland E. Schmieder, Giuseppe Mancia 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (X, 363 p. 19 illus., 13 illus. in color.) 225 1 $aUpdates in Hypertension and Cardiovascular Protection,$x2366-4606 311 $a3-319-34140-5 320 $aIncludes bibliographical references at the end of each chapters. 327 $aPart I Interventions for secondary hypertension - 1 Renovascular hypertension (Indications for intervention, Procedural aspects, Patient follow-up) -- 2 Primary hyperaldosteronism (Diagnosis and method of localization, Management algorithm and the role of interventional therapy, Outcome and follow-up) -- 3 Pheochromocytoma/paragangliomas (Confirmation of diagnosis, Preoperative management and surgical procedure, Follow-up: drugs, monitoring and other testing) -- 4 Coarctation of the aorta (Indications for intervention, Stenting versus surgical repair) -- Part II Adjunctive therapies - 5 Bariatric surgery ( Indications, Procedure types: safety and efficacy) -- 6 Sleep apnea (Pathophysiological aspects between sleep apnea and hypertension, Indications for screening, diagnosis and treatment, Positive airway pressure and other devices) -- Part III Interventions for Essential hypertension - 7 Rationale for interventions (The cerebrovascular impact of uncontrolled hypertension, The impact of uncontrolled hypertension on the heart, What to pay attention to before interventional therapy, Optimization of antihypertensive treatment, Blood pressure measurement before and after intervention, Adherence to medications, New pharmacological agents) -- 8 Renal Sympathetic Denervation (Pathophysiology, Procedural aspects, Safety, Efficacy on blood pressure, Effects beyond blood pressure lowering , Effects on sympathetic nervous system activity, Alternative methods for renal denervation) -- 9 Carotid baroreceptor stimulation (Pathophysiology, Procedural aspects, Safety and efficacy: overview) -- 10. Other interventions (Arteriovenous anastomosis, Carotid body modulation) -- 11 Heart Failure: Interventions for neuromodulation (Rationale, Current methods. A critical overview). 330 $aThis book aims to describe the role of interventional therapies in various forms of secondary hypertension and to explain the ability of such approaches to address unmet needs in the setting of uncontrolled essential hypertension. The coverage encompasses interventions in the full range of relevant conditions, including the various specific pathologies responsible for secondary hypertension, such as renal artery stenosis, coarctation of the aorta, and adrenal tumors. In each case, up-to-date information is presented on indications, procedural aspects, and patient follow-up. A further focus is the most recent knowledge on the use of invasive neuromodulation, such as renal sympathetic denervation and baroreflex stimulation. The text is supplemented by helpful explanatory diagrams and treatment algorithms. A comprehensive clinical guide of this nature has to date been absent from the literature. The book will be of interest to clinicians managing hypertensive patients, researchers investigating advanced hypertension management, and students on cardiology courses. 410 0$aUpdates in Hypertension and Cardiovascular Protection,$x2366-4606 606 $aCardiology 606 $aVascular surgery 606 $aNephrology 606 $aEndocrinology  606 $aCardiac surgery 606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aVascular Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59133 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 606 $aEndocrinology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33053 606 $aCardiac Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59028 615 0$aCardiology. 615 0$aVascular surgery. 615 0$aNephrology. 615 0$aEndocrinology . 615 0$aCardiac surgery. 615 14$aCardiology. 615 24$aVascular Surgery. 615 24$aNephrology. 615 24$aEndocrinology. 615 24$aCardiac Surgery. 676 $a616.12 702 $aTsioufis$b Costas$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSchmieder$b Roland E$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aMancia$b Giuseppe$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910254535003321 996 $aInterventional Therapies for Secondary and Essential Hypertension$92507314 997 $aUNINA